Previous 10 | Next 10 |
Dan Loeb's 13F portfolio value increased from ~$13B to $14.83B this quarter. The number of positions increased from 73 to 125. Third Point added Paysafe, CoStar Group, and Uber Technologies while dropping Alibaba Group Holdings and Fidelity National Information Services. The top t...
RiverPark Long/Short Opportunity seeks long-term capital appreciation while managing downside volatility by investing long in equity securities that RiverPark Advisors, LLC, the Fund's investment adviser, believes have above-average growth prospects and selling short equity securities the...
IQVIA Holdings Inc. (NYSE:IQV) traded at a new 52-week high today of $243.44. Approximately 150,000 shares have changed hands today, as compared to an average 30-day volume of 1.1 million shares. IQVIA Holdings Inc. (NYSE:IQV) is currently priced 33.1% above its average consensus analyst...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the William Blair Growth Stock Conference on Wednesday, June 2, 2021 at 10:20 a.m. EDT. A ...
Funding for early- and late-stage R&D and strategic transactions increased significantly in 2020; aggregate R&D spend for the top 15 companies reached a record high The number of first-time launches of novel active substances (NAS) reached an all-time high of 66 in...
Clinical-stage biomedical company ProtoKinetix (PKTX) and IQVIA (IQV) enter into a collaboration to accelerate the development of AAGP (PKX-001) in ocular conditions, specifically dry eye disease and wet and dry forms of age-related macular degeneration.The collaboration is expected to d...
Despite Disinformation Attempt, Antitrust Case Against IQVIA Moves Forward and Report of FTC Investigation of IQVIA Comes to Light IQVIA continues unethical tactics to divert attention from industry-wide issue: IQVIA monopoly abuse harms life sciences companies and patients ...
Court ruled that Veeva intended to commit fraud; destroyed evidence; engaged in theft, and cover-up IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced that the U.S. Di...
William von Mueffling's 13F portfolio value increased this quarter from $13.34B to $13.74B. Cantillon added Citrix Systems, IQVIA Holdings, & Nielsen Holdings while reducing Analog Devices, Willis Towers Watson, CBRE Group, Ecolab, & Zoetis. The portfolio continues to be v...
IQVIA (NYSE: IQV) announced today that it will collaborate with Corium, Inc – a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies – to support the launch of AZSTARYS™, which was a...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...